C ardiac resynchronization therapy (CRT) has been established as a useful therapy for patients with heart failure with abnormal QRS duration and low ejection fraction (EF). Although the vast majority of patients treated with CRT have a left bundle branch block (LBBB) QRS morphology, since the introduction of CRT into clinical practice, a growing number of patients with right bundle branch block (RBBB) QRS morphology or diffuse intraventricular conduction abnormality have been treated. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] As shown in Table 1, the most recently conducted studies report a variable proportion of patients with RBBB ≤18%. Thus, these patients represent a sizeable subgroup in need of adjunct therapies on top of the best pharmacological therapy. This percentage is most likely an underestimation of the true number of patients with heart failure and RBBB, because CRT in patients with RBBB has been controversial from the beginning, although QRS widening ≥120 ms was the only ECG selection criterion for CRT. More recently, several studies have shown that non-LBBB patients benefit less from CRT than those with LBBB.20,21 As a consequence, European Society of Cardiology guidelines indicate the use of CRT in non-LBBB patients with a QRS duration >150 ms at class IIa/level of evidence B, whereas guidelines suggest the use of CRT in non-LBBB patients with a QRS duration between 120 and 150 ms at a lower recommendation class (class IIb, level of evidence B).
22
Response by Kenneth Bilchick on p 542Although several factors may be held accountable for the diverse response to CRT in RBBB compared with LBBB, they have not been systematically reviewed. However, several retrospectively conducted studies have suggested that CRT may be beneficial in subgroups of patients with RBBB. In the present article, we are taking a mechanistic approach to evaluate the effect of CRT in patients with heart failure diagnosed with RBBB. Thus, we will review the electrophysiological findings, the mechanical abnormalities observed in patients with RBBB, and finally the clinical results of CRT in this patient subgroup to address a key question: is RBBB an inappropriate indication for CRT or is CRT applied in the wrong way in patients with RBBB?
Right and Left Ventricular Electric Activation in Patients With RBBBThe relative fragility and mechanical structure of the rightsided conduction system may explain the high incidence of this conduction delay in the general population without evidence of structural heart disease. In the Framingham study, RBBB and LBBB developed in 70 and 55 patients, respectively, during 18-year follow-up in 5826 healthy individuals.
23The Moli-sani study, which recruited 24 090 subjects in the central-southern region of Italy, 24 reported that RBBB was recorded in 589 individuals (2.44%), whereas LBBB was recorded in 181 individuals (0.75%); interestingly, RBBB was more frequent in men (3.4%) than in women (1.0%), whereas LBBB was slightly more frequent in women (0.9%) than in (Circ Ar...